News

MTN Japan Deploys FutureDial NDSE™ Solution for Automating the Data-...

Simultaneous Data Erasure for Multiple Network Routers, Switches, and Other Network Equipment TOKYO and SUNNYVALE, Calif., June 3, 2024 /PRNewswire/ -...

DB HiTek Advances Global Shutter and SPAD

Expanding specialized image sensor business applied to machine vision, autonomous vehicles, robotics, and medical devices Collaborating on product de...

Kerry Logistics Network Named Global Logistics Company of Excellence...

HONG KONG, June 3, 2024 /PRNewswire/ -- Kerry Logistics Network Limited ('Kerry Logistics Network', 'KLN'; Stock Code 0636.HK) has been named the Glob...

La Francaise De L'energie : Fde Buys Back Some Of Its Share Issued C...

FDE buys back some of its share issued capital via its buy-back program Pontpierre, France, June 3rd, 2024 - FDE (Euronext: FDE - ISIN: FR0013030152),...

Rokid AR Lite Crowdfunding Surpasses $600,000 with One Day Left for...

REDWOOD CITY, Calif. , June 2, 2024 /PRNewswire/ -- Rokid, a pioneer in augmented reality (AR) technology, has achieved a significant milestone i...

LENNY KRAVITZ ROCKS OUT AT THE UEFA CHAMPIONS LEAGUE FINAL KICK OFF...

MILLIONS TUNED IN FROM ACROSS THE WORLD TO SEE THE LEGENDARY ARTIST'S UNFORGETTABLE PERFORMANCE AHEAD OF THE BIGGEST GAME IN CLUB FOOTBALL Watch the U...

Innovent Announces Taletrectinib（ROS1 Inhibitor）Updated Data from...

SAN FRANCISCO and SUZHOU, China, June 2, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopha...

Jacobio Pharma Presents SHP2 Plus KRAS G12C Data at ASCO

BEIJING and SHANGHAI and CHICAGO, June 2, 2024 /PRNewswire/ -- Jacobio Pharma (1167.HK), a clinical-stage oncology company focusing on undruggable tar...

CStone Announces European Medicine Agency CHMP Recommends Approval o...

EMA CHMP recommendation is based on the results of a Phase 3 clinical trial (GEMSTONE-302) demonstrating significant progression-free survival (PFS)...

Innovent Presents Phase 1 Clinical Data of First-in-class PD-1/IL-2α...

SAN FRANCISCO, U.S. and SUZHOU, China, June 2, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class bioph...

Innovent Announces Data from Pivotal Phase 2 TRUST-I Study of Taletr...

SAN FRANCISCO, U.S. and SUZHOU, China, June 2, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class bioph...

Innovent Presents at the 2024 ASCO Annual Meeting on Clinical Data o...

SAN FRANCISCO, U.S. and SUZHOU, China, June 2, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class bioph...

GenFleet Therapeutics Announces Efficacy & Safety Result from Phase...

SHANGHAI and CHICAGO, June 2, 2024 /PRNewswire/ -- GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in...

Immunofoco Biotech to Unveil Solid Tumor CAR-T Programs Clinical Tri...

CHICAGO, June 2, 2024 /PRNewswire/ -- On June 1st, 2024, Immunofoco Biotech, a company dedicated to developing cell therapy products for solid tumors,...

Z Grills Announces Unprecedented "Buy 1, Get 10 Grills" Promotion, U...

ONTARIO, Calif., June 1, 2024 /PRNewswire/ -- Mark your calendars, grill masters! Z Grills, the innovator in premium wood pellet grills, is sizzling u...

ICECO Launches APL35 on Indiegogo - The World's Lightest Aluminum Du...

BREA, Calif., June 1, 2024 /PRNewswire/ -- ICECO, a leading expert in portable refrigeration solutions, announces the launch of the world's lightest d...

Tag along with Jason in Zhengzhou: Experiencing Kung Fu at the Shaol...

BEIJING, May 30, 2024 /PRNewswire/ -- This is a report from China.org.cn about the Shaolin Temple:  Guided by a friend...

Immunocan Launches Innovative Alpaca-derived Nanobody Discovery Plat...

BOSTON, June 1, 2024 /PRNewswire/ -- Immunocan announces significant progress in the construction of its alpaca-derived nanobody discovery platform, I...

TiumBio Presents Phase 1b Interim Results for TU2218 in Combination...

Poster presentation features the interim data from an ongoing Phase 1b clinical trial of TU2218 plus Keytruda combination therapy in pati...

Ivonescimab in Combination with Chemotherapy Approved in China by NM...

Separate & Distinct from HARMONi-2 Announcement, HARMONi-A Showed Clinically Meaningful and Statistically Significant Benefit: PFS Hazard Ratio of...